Press-release for stocks for novartis ag for nvsef

entities : Novartis ag symbols : Nvsef

save search

Viral Vector and Plasmid DNA Technologies: A Global Market Perspective
Published: 2024-04-17 (Crawled : 10:00) - prnewswire.com
TMO | News | $544.01 0.46% 470K

Health Technology

| -4.36% | O: -0.26% H: 0.03% C: -1.55%
NVS | $93.81 1.34% 1.2M

Health Technology

| 0.28% | O: 0.87% H: 0.16% C: -0.59%
RGNX | $15.49 -3.85% 210K

Health Technology

| -4.57% | O: -1.43% H: 2.27% C: -3.18%
global dna market

Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment- naïve people with relapsing multiple sclerosis
Published: 2024-04-17 (Crawled : 06:00) - globenewswire.com
NVS | $93.81 1.34% 1.2M

Health Technology

| 0.28% | O: 0.87% H: 0.16% C: -0.59%
kesimpta sclerosis novartis show benefits

Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published: 2024-04-16 (Crawled : 14:00) - prnewswire.com
VTRS | $11.23 0.99% 1.5M

Health Technology

| -1.77% | O: -0.53% H: 0.0% C: -1.24%
NVS | $93.81 1.34% 1.2M

Health Technology

| -1.19% | O: -1.46% H: 0.0% C: 0.0%
PHG | $20.0 0.1% 340K

Health Technology

| -2.52% | O: -1.21% H: 0.0% C: 0.0%
GSK | $39.605 0.85% 790K

Health Technology

| -2.22% | O: -1.19% H: 0.52% C: -0.17%
VRNA | $15.66 -2.73% 190K

Health Technology

| 1.9% | O: 1.65% H: 2.43% C: 0.87%
reach treatment research market

Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
NVS | $93.81 1.34% 1.2M

Health Technology

| -1.19% | O: -1.46% H: 0.0% C: 0.0%
REGN | $894.71 0.08% 180K

Health Technology

| -1.51% | O: -1.94% H: 0.43% C: -0.34%
OCUL | News | $5.165 -11.86% 5.1M

Health Technology

| -3.1% | O: -1.03% H: 3.66% C: 1.7%
ocular key leaders

Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published: 2024-04-15 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 600K

Health Technology

| -0.29% | O: -1.75% H: 0.85% C: 0.85%
AZNCF | $138.24 800

Health Technology

| -0.47% | O: 2.1% H: 0.0% C: -2.52%
NVS | $93.81 1.34% 1.2M

Health Technology

| -1.19% | O: -1.46% H: 0.0% C: 0.0%
GSK | $39.605 0.85% 790K

Health Technology

| -2.22% | O: -1.19% H: 0.52% C: -0.17%
BAX | $39.545 -0.27% 690K

Health Technology

| -0.85% | O: -0.1% H: 0.13% C: -1.08%
ABBV | News | $166.43 1.08% 2M

Health Technology

| 2.16% | O: 0.32% H: 0.96% C: 0.22%
SNY | News | $46.545 2.55% 2.3M

Health Technology

| -2.9% | O: -2.13% H: 0.0% C: 0.0%
BMRN S | $88.95 -1.24% 1.1M

Health Technology

| -0.46% | O: -0.72% H: 0.0% C: 0.0%
AZN | $68.3 -0.09% 2M

Health Technology

| -0.68% | O: -0.64% H: 0.45% C: -0.04%
AMGN | $267.41 1.77% 1.4M

Health Technology

| -0.22% | O: 0.41% H: 0.0% C: 0.0%
set therapeutics market

New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)
Published: 2024-04-15 (Crawled : 18:00) - globenewswire.com
NVS | $93.81 1.34% 1.2M

Health Technology

| -1.19% | O: -1.46% H: 0.0% C: 0.0%
fabhalta nephropathy for novartis show

Novartis tender offer for MorphoSys AG commences
Published: 2024-04-11 (Crawled : 09:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K

Health Technology

| -0.49% | O: -0.32% H: 0.48% C: -0.17%
NVS | $93.81 1.34% 1.2M

Health Technology

| -1.57% | O: 0.32% H: 0.04% C: -0.56%
MOR | $17.96 -0.5% 72K

Health Technology

| 0.31% | O: 0.69% H: 0.0% C: -0.39%
for novartis

Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published: 2024-04-10 (Crawled : 09:00) - prnewswire.com
ALPMF | $9.17 16K

Health Technology

| -10.96% | O: -100.0% H: NaN% C: Infinity%
SNYNF | News | $92.7 600K

Health Technology

| -1.65% | O: -0.01% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

Health Technology

| -2.16% | O: -1.67% H: 0.0% C: 0.0%
ALPMY | $9.47 520K

Manufacturing

| -10.79% | O: -0.29% H: 0.0% C: -1.97%
VTRS | $11.23 0.99% 1.5M

Health Technology

| -5.12% | O: -0.6% H: 1.03% C: 0.52%
TMO | News | $544.01 0.46% 470K

Health Technology

| -9.54% | O: -2.01% H: 0.0% C: 0.0%
NVS | $93.81 1.34% 1.2M

Health Technology

| -2.71% | O: -1.16% H: 0.0% C: 0.0%
SNY | News | $46.545 2.55% 2.3M

Health Technology

| -4.25% | O: -0.32% H: 0.0% C: 0.0%
JAZZ | $110.6 1.22% 210K

Health Technology

| -7.38% | O: -1.71% H: 0.57% C: 0.37%
disorders system set market

Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 600K

Health Technology

| 0.01% | O: 2.24% H: 0.0% C: -0.8%
AZNCF | $138.24 800

Health Technology

| 1.57% | O: -3.43% H: 6.21% C: 6.21%
VTRS | $11.23 0.99% 1.5M

Health Technology

| -5.76% | O: -0.25% H: 1.1% C: -0.17%
NVS | $93.81 1.34% 1.2M

Health Technology

| -2.83% | O: -0.05% H: 0.43% C: -0.27%
BMY | $48.89 1.22% 5.1M

Health Technology

| -5.88% | O: -0.08% H: 0.04% C: -0.35%
BHC | $8.63 0.35% 1.5M

Health Technology

| -16.04% | O: 0.38% H: 0.0% C: -7.27%
ABBV | News | $166.43 1.08% 2M

Health Technology

| -1.64% | O: 0.77% H: 1.63% C: 0.35%
SNY | News | $46.545 2.55% 2.3M

Health Technology

| -3.02% | O: 0.84% H: 0.0% C: 0.0%
AZN | $68.3 -0.09% 2M

Health Technology

| 1.21% | O: 0.18% H: 0.3% C: 0.19%
eczema dermatitis set therapeutics market

New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting
Published: 2024-04-06 (Crawled : 20:20) - globenewswire.com
NVSEF | $93.6375 6.88% 82K

Health Technology

| Email alert Add to watchlist
NVS | $93.81 1.34% 1.2M

Health Technology

| Email alert Add to watchlist
leqvio novartis therapy show

Positron Emission Tomography Market size is set to grow by USD 725.97 mn from 2024-2028,increasing prevalence of chronic conditions worldwide boost the market- Technavio
Published: 2024-04-03 (Crawled : 06:00) - prnewswire.com
CAJPY | News | $28.42 29K

n/a

| -3.18% | O: -0.3% H: 0.54% C: 0.54%
CAJFF | News | $29.0664 760

Electronic Technology

| -2.61% | O: -100.0% H: NaN% C: Infinity%
NVSEF | $93.6375 6.88% 82K

Health Technology

| -1.43% | O: -2.86% H: 0.17% C: 0.17%
NVS | $93.81 1.34% 1.2M

Health Technology

| -1.41% | O: 0.04% H: 0.46% C: -0.08%
PHG | $20.0 0.1% 340K

Health Technology

| 1.15% | O: 1.0% H: 0.0% C: 0.0%
worldwide set market

NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
NAMS | $19.94 2.57% 77K

n/a

| -10.51% | O: 6.23% H: 2.77% C: -10.21%
NVS | $93.81 1.34% 1.2M

Health Technology

| -3.42% | O: 0.47% H: 0.23% C: -0.99%
pharma business

Carisma Therapeutics Announces Changes to its Board of Directors
Published: 2024-04-01 (Crawled : 11:00) - prnewswire.com
NVS | $93.81 1.34% 1.2M

Health Technology

| -3.42% | O: 0.47% H: 0.23% C: -0.99%
CRIS | $14.51 -4.67% 4.8K

Health Technology

| 41.72% | O: 0.7% H: 16.87% C: 16.87%
therapeutics

Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published: 2024-03-29 (Crawled : 18:00) - prnewswire.com
BMY | $48.89 1.22% 5.1M

Health Technology

| Email alert Add to watchlist
GILD | News | $66.45 0.44% 4.3M

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 600K

Health Technology

| Email alert Add to watchlist
AMGN | $267.41 1.77% 1.4M

Health Technology

| Email alert Add to watchlist
GMAB | $28.68 1.23% 150K

Health Technology

| Email alert Add to watchlist
SNY | News | $46.545 2.55% 2.3M

Health Technology

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K

Health Technology

| Email alert Add to watchlist
NVS | $93.81 1.34% 1.2M

Health Technology

| Email alert Add to watchlist
GNMSF | $290.38 220

Health Technology

| Email alert Add to watchlist
ABBV | News | $166.43 1.08% 2M

Health Technology

| Email alert Add to watchlist
research global leukemia therapeutics market

LASIK Surgery Market size to record USD 1.24 bn growth from 2024-2028, Increasing medical tourism for LASIK surgery is one of the key market trends, Technavio
Published: 2024-03-28 (Crawled : 22:00) - prnewswire.com
NVS | $93.81 1.34% 1.2M

Health Technology

| Email alert Add to watchlist
ABT | News | $106.76 1.42% 3.8M

Health Technology

| Email alert Add to watchlist
ALC | $79.43 1.22% 760K

Health Technology

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K

Health Technology

| Email alert Add to watchlist
one key medical growth market

CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
Published: 2024-03-28 (Crawled : 19:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K

Health Technology

| Email alert Add to watchlist
NVS | $93.81 1.34% 1.2M

Health Technology

| Email alert Add to watchlist
AVEO | $15.0 0.0% 0

Health Technology

| Email alert Add to watchlist
AUTL | $4.635 -3.44% 740K

Health Technology

| Email alert Add to watchlist
medical

Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published: 2024-03-28 (Crawled : 15:30) - prnewswire.com
GLAXF | $20.2 510

Health Technology

| -4.72% | O: 0.99% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

Health Technology

| -2.13% | O: -100.0% H: NaN% C: Infinity%
NVS | $93.81 1.34% 1.2M

Health Technology

| -2.92% | O: 0.52% H: 0.0% C: 0.0%
JNJ | News | $147.17 0.98% 3.2M

Health Technology

| -7.14% | O: 1.32% H: 0.0% C: 0.0%
GSK | $39.605 0.85% 790K

Health Technology

| -7.89% | O: 0.02% H: 0.51% C: -0.3%
LLY | $727.48 -2.48% 2M

Health Technology

| -3.52% | O: 0.28% H: 1.71% C: -0.3%
BMY | $48.89 1.22% 5.1M

Health Technology

| -9.3% | O: 0.26% H: 2.03% C: 1.57%
AMGN | $267.41 1.77% 1.4M

Health Technology

| -7.46% | O: 0.54% H: 0.0% C: 0.0%
antibody research global

Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-03-27 (Crawled : 22:00) - prnewswire.com
GLAXF | $20.2 510

Health Technology

| -4.72% | O: 0.99% H: 0.0% C: 0.0%
SNYNF | News | $92.7 600K

Health Technology

| -7.02% | O: -1.17% H: 0.0% C: -0.89%
AZNCF | $138.24 800

Health Technology

| 0.45% | O: 0.89% H: 0.78% C: 0.78%
NVSEF | $93.6375 6.88% 82K

Health Technology

| -2.13% | O: -100.0% H: NaN% C: Infinity%
NVS | $93.81 1.34% 1.2M

Health Technology

| -2.92% | O: 0.52% H: 0.0% C: 0.0%
GSK | $39.605 0.85% 790K

Health Technology

| -7.89% | O: 0.02% H: 0.51% C: -0.3%
BMY | $48.89 1.22% 5.1M

Health Technology

| -9.3% | O: 0.26% H: 2.03% C: 1.57%
ABBV | News | $166.43 1.08% 2M

Health Technology

| -8.42% | O: 0.36% H: 0.72% C: 0.61%
ABT | News | $106.76 1.42% 3.8M

Health Technology

| -5.06% | O: 1.04% H: 0.0% C: 0.0%
SNY | News | $46.545 2.55% 2.3M

Health Technology

| -8.47% | O: -0.96% H: 0.0% C: 0.0%
AZN | $68.3 -0.09% 2M

Health Technology

| 0.01% | O: -0.12% H: 0.25% C: -0.63%
AMGN | $267.41 1.77% 1.4M

Health Technology

| -7.46% | O: 0.54% H: 0.0% C: 0.0%
abbvie set canada key market

Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
Published: 2024-03-27 (Crawled : 20:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K

Health Technology

| -2.13% | O: -100.0% H: NaN% C: Infinity%
ERAS | $1.77 -1.12% 270K

| -6.31% | O: 17.48% H: 6.94% C: -14.88%
NVS | $93.81 1.34% 1.2M

Health Technology

| -2.92% | O: 0.52% H: 0.0% C: 0.0%
LLY | $727.48 -2.48% 2M

Health Technology

| -3.52% | O: 0.28% H: 1.71% C: -0.3%
business year financial results

Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
Published: 2024-03-27 (Crawled : 11:00) - biospace.com/
CRBU | $3.88 -0.77% 650K

Health Technology

| -20.75% | O: 1.58% H: 0.58% C: -0.39%
NVS | $93.81 1.34% 1.2M

Health Technology

| -2.3% | O: 0.24% H: 0.42% C: 0.4%
LLY | $727.48 -2.48% 2M

Health Technology

| -3.11% | O: 0.49% H: 0.84% C: -0.07%
TGTX | News | $13.685 -2.18% 1.9M

Health Technology

| -9.39% | O: 0.71% H: 0.39% C: 0.13%
DTIL | $9.985 -6.86% 93K

Health Technology

| -15.92% | O: 0.39% H: 4.22% C: 1.41%
precision business year update financial results

← Previous
1
2
3
4
5
6
7
8
9
…
51
52
Next →

entities : Novartis ag symbols : Nvsef

save search

Gainers vs Losers

Top 10 Gainers

Your saved searches

entities : Novartis ag symbols : Nvsef save search

Gainers vs Losers

Top 10 Gainers

Your saved searches

entities : Novartis ag symbols : Nvsef

save search